Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

Saved in:
Bibliographic Details
Other Authors: Höhler, Thomas (Other) , Hofheinz, Ralf-Dieter (Other)
Format: Article (Journal)
Language:English
Published: 2013
In: British journal of cancer
Year: 2013, Volume: 109, Issue: 6, Pages: 1408-1413
ISSN:1532-1827
Online Access:Verlag, Volltext: http://www.nature.com/bjc/journal/v109/n6/full/bjc2013409a.html
Get full text
Author Notes:Hoehler, T. ... Hofheinz, R. ...

MARC

LEADER 00000caa a22000002c 4500
001 1484866487
003 DE-627
005 20220811123437.0
007 cr uuu---uuuuu
008 140925s2013 xx |||||o 00| ||eng c
024 7 |a 10.1038/bjc.2013.409  |2 doi 
035 |a (DE-627)1484866487 
035 |a (DE-576)414866487 
035 |a (DE-599)BSZ414866487 
035 |a (OCoLC)1340650197 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer  |b AIO KRK 0205  |c Hoehler, T. ... Hofheinz, R. ... 
264 1 |c 2013 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am: 25.09.2014 
700 1 |a Höhler, Thomas  |0 (DE-588)1014334748  |0 (DE-627)705210782  |0 (DE-576)348629044  |4 oth 
700 1 |a Hofheinz, Ralf-Dieter  |d 1969-  |0 (DE-588)121917517  |0 (DE-627)08161876X  |0 (DE-576)292991568  |4 oth 
773 0 8 |i In  |t British journal of cancer  |d Edinburgh : Nature Publ. Group, 1947  |g 109(2013), 6, Seite 1408-1413  |h Online-Ressource  |w (DE-627)320420094  |w (DE-600)2002452-6  |w (DE-576)103746854  |x 1532-1827  |7 nnas  |a Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer AIO KRK 0205 
773 1 8 |g volume:109  |g year:2013  |g number:6  |g pages:1408-1413  |g extent:6  |a Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer AIO KRK 0205 
856 4 0 |u http://www.nature.com/bjc/journal/v109/n6/full/bjc2013409a.html  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20140925 
993 |a Article 
994 |a 2013 
998 |g 121917517  |a Hofheinz, Ralf-Dieter  |m 121917517:Hofheinz, Ralf-Dieter  |d 60000  |d 61200  |e 60000PH121917517  |e 61200PH121917517  |k 0/60000/  |k 1/60000/61200/  |p 12 
999 |a KXP-PPN1484866487  |e 2816392775 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Hoehler, T. ... Hofheinz, R. ..."]},"person":[{"family":"Höhler","role":"oth","given":"Thomas","display":"Höhler, Thomas"},{"role":"oth","given":"Ralf-Dieter","display":"Hofheinz, Ralf-Dieter","family":"Hofheinz"}],"origin":[{"dateIssuedDisp":"2013","dateIssuedKey":"2013"}],"recId":"1484866487","type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"6 S."}],"id":{"eki":["1484866487"],"doi":["10.1038/bjc.2013.409"]},"note":["Gesehen am: 25.09.2014"],"relHost":[{"pubHistory":["Volume 1, issue 1 (1 March 1947)-"],"title":[{"title":"British journal of cancer","subtitle":"BJC","title_sort":"British journal of cancer"}],"part":{"year":"2013","text":"109(2013), 6, Seite 1408-1413","volume":"109","issue":"6","pages":"1408-1413","extent":"6"},"language":["eng"],"titleAlt":[{"title":"BJC"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"320420094","origin":[{"publisherPlace":"Edinburgh ; Edinburgh","publisher":"Nature Publ. Group ; Churchill Livingstone","dateIssuedDisp":"1947-","dateIssuedKey":"1947"}],"disp":"Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer AIO KRK 0205British journal of cancer","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2002452-6"],"issn":["1532-1827"],"eki":["320420094"]},"note":["Gesehen am 27.10.25"]}],"title":[{"subtitle":"AIO KRK 0205","title":"Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer","title_sort":"Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer"}],"language":["eng"]} 
SRT |a PHASEIIITR2013